BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18759374)

  • 1. Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression.
    Verdelli D; Nobili L; Todoerti K; Intini D; Cosenza M; Civallero M; Bertacchini J; Deliliers GL; Sacchi S; Lombardi L; Neri A
    Hematol Oncol; 2009 Mar; 27(1):23-30. PubMed ID: 18759374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling of enzastaurin-treated B cell lymphoma RL cells.
    Civallero M; Cosenza M; Neri A; Bari A
    Hematol Oncol; 2011 Sep; 29(3):154-6. PubMed ID: 21922509
    [No Abstract]   [Full Text] [Related]  

  • 3. Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targeting.
    Cassinelli G; Ronchetti D; Laccabue D; Mattioli M; Cuccuru G; Favini E; Nicolini V; Greco A; Neri A; Zunino F; Lanzi C
    Biochem Pharmacol; 2009 Nov; 78(9):1139-47. PubMed ID: 19555670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response.
    Lopez-Girona A; Heintel D; Zhang LH; Mendy D; Gaidarova S; Brady H; Bartlett JB; Schafer PH; Schreder M; Bolomsky A; Hilgarth B; Zojer N; Gisslinger H; Ludwig H; Daniel T; Jäger U; Chopra R
    Br J Haematol; 2011 Aug; 154(3):325-36. PubMed ID: 21707574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines.
    Neri A; Marmiroli S; Tassone P; Lombardi L; Nobili L; Verdelli D; Civallero M; Cosenza M; Bertacchini J; Federico M; De Pol A; Deliliers GL; Sacchi S
    Leuk Lymphoma; 2008 Jul; 49(7):1374-83. PubMed ID: 18452078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
    Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
    Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of PKCbeta in the malignant tumors and enzastaurin, a PKCbeta inhibitor].
    Li XY; Chen XG
    Yao Xue Xue Bao; 2009 May; 44(5):449-55. PubMed ID: 19618717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells.
    Raje N; Kumar S; Hideshima T; Ishitsuka K; Yasui H; Chhetri S; Vallet S; Vonescu E; Shiraishi N; Kiziltepe T; Elford HL; Munshi NC; Anderson KC
    Br J Haematol; 2006 Oct; 135(1):52-61. PubMed ID: 16925573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of protein kinase C sensitise multiple myeloma cells to common genotoxic drugs.
    Baumann P; Armann J; Mandl-Weber S; Grün G; Oduncu F; Schmidmaier R
    Eur J Haematol; 2008 Jan; 80(1):37-45. PubMed ID: 18028419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.
    Olivier S; Close P; Castermans E; de Leval L; Tabruyn S; Chariot A; Malaise M; Merville MP; Bours V; Franchimont N
    Mol Pharmacol; 2006 May; 69(5):1615-23. PubMed ID: 16497877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lymphocyte function associated antigen 1 by LFA878 induces apoptosis in multiple myeloma cells and is associated with downregulation of the focal adhesion kinase/phosphatidylinositol 3 kinase/Akt pathway.
    Schmidmaier R; Mandl-Weber S; Gaul L; Baumann P; Bumeder I; Straka C; Emmerich B
    Int J Oncol; 2007 Oct; 31(4):969-76. PubMed ID: 17786331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl).
    Podar K; Raab MS; Zhang J; McMillin D; Breitkreutz I; Tai YT; Lin BK; Munshi N; Hideshima T; Chauhan D; Anderson KC
    Blood; 2007 Feb; 109(4):1669-77. PubMed ID: 17023575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1.
    Gojo I; Zhang B; Fenton RG
    Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzastaurin, a protein kinase Cbeta- selective inhibitor, and its potential application as an anticancer agent in lung cancer.
    Herbst RS; Oh Y; Wagle A; Lahn M
    Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4641-6. PubMed ID: 17671157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
    Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer: An unexpected addiction.
    Shaughnessy JD
    Nature; 2008 Jul; 454(7201):172-3. PubMed ID: 18615074
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene-expression profiling during curcumin-induced apoptosis reveals downregulation of CXCR4.
    Skommer J; Wlodkowic D; Pelkonen J
    Exp Hematol; 2007 Jan; 35(1):84-95. PubMed ID: 17198877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling.
    Raab MS; Breitkreutz I; Tonon G; Zhang J; Hayden PJ; Nguyen T; Fruehauf JH; Lin BK; Chauhan D; Hideshima T; Munshi NC; Anderson KC; Podar K
    Blood; 2009 Feb; 113(7):1513-21. PubMed ID: 19018094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile of multiple myeloma cell line treated by realgar.
    Wang MC; Liu SX; Liu PB
    J Exp Clin Cancer Res; 2006 Jun; 25(2):243-9. PubMed ID: 16918137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzastaurin.
    Ma S; Rosen ST
    Curr Opin Oncol; 2007 Nov; 19(6):590-5. PubMed ID: 17906457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.